Patent Yard Sign in
Canadian application, no grantCanada

Human proteins having secretory signal sequences and dnas encoding these proteins

CA 2265923 A1 · Owner: Protegene Inc. · Inventors: Kimura, Tomoko; Kato, Seishi; Sekine, Shingo

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Problems to be solved To provide human proteins having secretory signal sequences and cDNAs encoding said proteins. Means to solve the problems Proteins containing any of the amino acid sequences represented by Sequence No. 1 to Sequence No. 9 and DNAs encoding said proteins exemplified by cDNAs containing any of the base sequences represented by Sequence No. 10 to Sequence No. 18. Said proteins can be provided by expressing cDNAs encoding human proteins having secretory signal sequences with verified secretory functions and recombinants of these human cDNAs.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 12, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 12, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 12, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 12, 1997
GrantedNo grant recorded
Term endedSeptember 12, 2017
Patent numberCA 2265923 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedSep 12, 1997Term endedSep 12, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.